GeneHarmonics Inc.

Core Beliefs: • Creating innovative enterprise solutions with social relevance. • Anchoring our initiatives to existing global and/or regional infrastructures for accelerated growth. • The principle that success should be measured using both financial and social impact metrics. GeneHarmonics Inc., is a next generation medical technology company in 2021. GeneHarmonics leverages converging technologies to enhance medical diagnostics. GeneHarmonics’ foundational technology has the capability to test various biomarker classifications inclusive of, but not limited to, infectious diseases, direct to consumer tests, and population studies, etc. The Harmonics Group of Companies formally started 2.5 years ago and has grown revenue to 8-figures in a short span of time. Exposed to the interplay between technology companies and the capital market in Silicon Valley, GeneHarmonics created and implemented a non-traditional plan to create a funding engine for the diagnostics platform. This strategy is inclusive of consolidating end-to-end self-sustaining verticals globally to help address societal needs. The Harmonics Group is composed of companies structured around the principles of social entrepreneurship. The Harmonics Group adheres to the strict strategic planning principles, consolidation, and the accelerated implementation of out-of-the box solutions to address several critical issues inclusive of, but not limited to: data-enabled portable devices to be used as research tools for the management of infectious diseases; the human resources crisis in major economies; creating better healthcare solutions for applicable US workforce.